Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. - Wikidata - awgldk - TriplyDB

Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases.

Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases.

http://www.wikidata.org/entity/Q33519056

about

Cancer imaging by optical coherence tomography: preclinical progress and clinical potential.In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine.Secreted luciferase for in vivo evaluation of systemic protein delivery in mice Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases Successful establishment of an orthotopic hepatoblastoma in vivo model in NOD/LtSz-scid IL2Rγnull mice.The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy.Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade.Multimodal in vivo imaging and blood monitoring of intrinsic and extrinsic apoptosis.Secreted Gaussia princeps luciferase as a reporter of Escherichia coli replication in a mouse tissue cage model of infection Secreted blood reporters: insights and applications.The biology of brain metastases-translation to new therapies Exogenous marker-engineered mesenchymal stem cells detect cancer and metastases in a simple blood assay.FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells.Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases Evaluation of Gaussia luciferase and foot-and-mouth disease virus 2A translational interrupter chimeras as polycistronic reporters for transgene expression Reporter gene imaging of immune responses to cancer: progress and challenges.The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer.The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancers Targeting miR-21 for the therapy of pancreatic cancer NFκB and HIF display synergistic behaviour during hypoxic inflammation.Enhanced Gaussia luciferase blood assay for monitoring of in vivo biological processes.Noninvasive Monitoring of Glioma Growth in the Mouse.Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases.Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer A water-soluble coelenterazine for sensitive in vivo imaging of coelenterate luciferases.Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.Non-invasive detection of bladder cancer via expression-targeted gene delivery.Maintaining unperturbed cerebral blood flow is key in the study of brain metastasis and its interactions with stress and inflammatory responses.Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity.A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.Optimized application of the secreted Nano-luciferase reporter system using an affinity purification strategy.Exploiting in vitro and in vivo bioluminescence for the implementation of the three Rs principle (replacement, reduction, and refinement) in drug discovery

P2860

Q26823084-FA949B85-7682-4315-939A-F68E619D70EE Q27006069-ABDB2294-36BF-490A-A47E-9D156298ADD6 Q28972229-577FB7CC-44C5-4B33-B66C-1C3F9BDA2943 Q30461932-668EBE32-990A-447F-8A0D-276E04ABA9FA Q33693031-D58064A9-06C9-4FE0-88EA-0A0B37976CBC Q33764406-E3C416EF-357A-48F9-91B8-FEAA90CAFFAF Q33997175-45F8E585-1117-4642-B4B6-6E8AA2EF5FAA Q34576658-D61F1EEF-6B68-4AA1-8BC6-20D4BEDEA255 Q34777793-137B2E7E-FC72-4C94-A944-2DED117BC2DB Q35064453-F9D6FD4D-FEAF-4A72-BFF8-C470741ADE65 Q35086733-40763609-3A0E-4830-9085-DECEBBA1D45C Q35111384-E049CFBA-0E99-49BC-979A-945CF57AE7D8 Q35294368-C4074527-6DF8-458D-8F3B-1028D523B039 Q35676602-24761DBB-C714-4759-9E79-EBEC8E79982C Q36082553-D52AAE96-19B1-452B-9E9E-2549F39F547D Q36260612-A63A2644-CDFE-4FDB-A221-6E1E0B4641A6 Q36389339-55738947-DF56-4E47-907A-BD4E7AFCCED6 Q36399569-081A6A14-9CF1-43CA-9D9C-F4F5D15F1719 Q38003152-792C179F-3046-469E-9404-1598FD721D48 Q38259961-7E83A62A-31BB-416F-8563-A32B9181132F Q38766447-C240E80D-BA94-4E2E-B962-ED296F9137C1 Q39011065-DEBF4498-51B6-492A-846D-F007174DD4D8 Q39182251-F6B70AB8-63D6-4DF6-9950-EA8CBAA546A0 Q39446203-3B37BCEE-239F-4278-8BF3-5AE49C1F5434 Q40619313-8A60115A-2E2B-4EB3-A810-CE6F55B480B2 Q41201141-122F1535-8EF4-4E56-8518-989FBEC8B98C Q42224034-F035A64A-F945-4E28-8715-0280CF0C560B Q42234959-E26D6AA7-B52E-41D9-86C1-8F6BAB17009D Q42284089-A51B6BC1-61C5-4431-8B96-C9F99BFB976A Q42553879-09E687C8-F2FA-4421-A496-219E79D7E681 Q42644178-D63B449E-BD79-436C-87E0-40913CF553A2 Q47901349-B2553CC5-5EBB-46D9-A0B2-42E826EA18C8 Q48300160-D6F0295E-F477-4D96-8765-7FBC922FC545 Q48483233-3A789D0D-73E4-43DA-AAB9-4584B12FF73A Q50442410-F3B3E90C-1B01-40B0-A19D-05F9C301F26F Q52731753-89E29D79-97B4-4503-9C61-600F8E063AD9 Q54965253-8F1EAE14-41A4-46AD-BD04-FA1719298CA8 Q56973000-B5EA7F81-14B8-4A67-B793-573ED1658645

P2860

Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases.

http://www.wikidata.org/entity/Q33519056

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Secreted Gaussia luciferase as ...... sponse of systemic metastases.

@ast

Secreted Gaussia luciferase as ...... sponse of systemic metastases.

@en

Secreted Gaussia luciferase as ...... sponse of systemic metastases.

@nl

type

label

Secreted Gaussia luciferase as ...... sponse of systemic metastases.

@ast

Secreted Gaussia luciferase as ...... sponse of systemic metastases.

@en

Secreted Gaussia luciferase as ...... sponse of systemic metastases.

@nl

prefLabel

Secreted Gaussia luciferase as ...... sponse of systemic metastases.

@ast

Secreted Gaussia luciferase as ...... sponse of systemic metastases.

@en

Secreted Gaussia luciferase as ...... sponse of systemic metastases.

@nl

P1433

Q33519056-FE9E701D-86A6-4704-850B-12BA2EEED3DE

P1476

Q33519056-7B9272D6-C170-409A-B5B0-94A0D4B4E253

P2093

Q33519056-10755AA5-1A98-4AA8-B587-597849DF1FF2

Q33519056-36362AAD-3074-4E43-B2C2-595AE588D430

Q33519056-5C4F92B0-9A7A-4A53-B4E2-C8A40ED2ABB6

Q33519056-76BEBF42-E7DD-45C6-89FE-7E42CE49F6F2

Q33519056-B355EA9F-AA56-4CC3-B408-98FE85AF2C7F

P2860

Q33519056-0588EEE8-F165-429D-BEA8-41410B15D7A7

Q33519056-1EFE464E-B458-4F91-BD2A-B63C20727915

Q33519056-2DB7D185-1A2F-4D54-96E0-15AD317A31C0

Q33519056-35AB040C-CC77-4992-B66F-49AC02957C49

Q33519056-3A82E063-345A-4FAB-A84E-85F73136C8E5

Q33519056-519926AA-E450-4132-909D-66C5AC72D24A

Q33519056-5AC1E36E-2F3D-45DA-8AC1-7FAC9D0570DA

Q33519056-5D48BA73-2D2B-44B2-BBD8-D7B86FD4ECA3

Q33519056-61037CFF-10BB-4158-81E2-D8C0DDF53070

Q33519056-77ED07EB-04B0-4E5F-8ADB-5A0EC9DABA19

P304

Q33519056-8DB3F1FC-0B57-44D9-8726-66F2878F2217

P31

Q33519056-1A692BDC-8924-4E8E-B453-D52524F19413

P356

Q33519056-960175F7-F31C-4BE4-854F-A7F12F186D0B

P407

Q33519056-BD023B67-F79B-44ED-A8E2-5B2E54331A33

P433

Q33519056-F9A5F194-F65C-4FFD-8200-E29CE49B9611

P478

Q33519056-B0FFB6D7-1411-4305-A4F7-CF460BC760F4

P50

Q33519056-E1D591FF-EB83-4277-B692-43F76AFC8EA4

P577

Q33519056-F66CBC89-989B-4DED-BBDF-C92A0A2A6F8E

P5875

Q33519056-6691EDE5-A0DD-445F-A988-DBB6486959A6

P698

Q33519056-08D4204F-D1E8-403D-B926-989CA0A29B50

P921

Q33519056-405E66DB-27DE-48CC-83A5-A718F3F9ADDD

P932

Q33519056-594AC9FC-8027-40D9-B90A-C1B6C5DE9861

P356

JOURNAL.PONE.0008316

P1433

P1476

Secreted Gaussia luciferase as ...... sponse of systemic metastases.

@en

P2093

Bakhos A Tannous

http://www.w3.org/2001/XMLSchema#string

Dai Fukumura

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yamashita

http://www.w3.org/2001/XMLSchema#string

Patrick Au

http://www.w3.org/2001/XMLSchema#string

Rakesh K Jain

http://www.w3.org/2001/XMLSchema#string

P2860

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.

A highly sensitive assay for monitoring the secretory pathway and ER stress.

Optical imaging of Renilla luciferase reporter gene expression in living mice.

Molecular imaging in cancer.

Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells.

In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma.

Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain.

In vivo pathology: seeing with molecular specificity and cellular resolution in the living body.

Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo

A secreted luciferase for ex vivo monitoring of in vivo processes.

P304

e8316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0008316

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40694193

http://www.w3.org/2001/XMLSchema#string

P698

20016816

http://www.w3.org/2001/XMLSchema#string

P921

P932

2789383

http://www.w3.org/2001/XMLSchema#string